[1]
Rahman, M.S. , Karim, M.R. and Haque, M.A. 2023. Efficacy of Rifaximin in Diarrhoea Predominant Irritable Bowel Syndrome: A Placebo Controlled Clinical Trial. Medicine Today. 35, 1 (Apr. 2023), 44–48. DOI:https://doi.org/10.3329/medtoday.v35i1.64940.